IBDEI0HB ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7797,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7797,1,3,0)
 ;;=3^Tinea Imbricata
 ;;^UTILITY(U,$J,358.3,7797,1,4,0)
 ;;=4^B35.5
 ;;^UTILITY(U,$J,358.3,7797,2)
 ;;=^119725
 ;;^UTILITY(U,$J,358.3,7798,0)
 ;;=B35.4^^39^391^320
 ;;^UTILITY(U,$J,358.3,7798,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7798,1,3,0)
 ;;=3^Tinea Corporis
 ;;^UTILITY(U,$J,358.3,7798,1,4,0)
 ;;=4^B35.4
 ;;^UTILITY(U,$J,358.3,7798,2)
 ;;=^119704
 ;;^UTILITY(U,$J,358.3,7799,0)
 ;;=B35.8^^39^391^140
 ;;^UTILITY(U,$J,358.3,7799,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7799,1,3,0)
 ;;=3^Dermatophytoses,Other
 ;;^UTILITY(U,$J,358.3,7799,1,4,0)
 ;;=4^B35.8
 ;;^UTILITY(U,$J,358.3,7799,2)
 ;;=^5000606
 ;;^UTILITY(U,$J,358.3,7800,0)
 ;;=B36.9^^39^391^312
 ;;^UTILITY(U,$J,358.3,7800,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7800,1,3,0)
 ;;=3^Superficial Mycosis,Unspec
 ;;^UTILITY(U,$J,358.3,7800,1,4,0)
 ;;=4^B36.9
 ;;^UTILITY(U,$J,358.3,7800,2)
 ;;=^5000611
 ;;^UTILITY(U,$J,358.3,7801,0)
 ;;=D69.0^^39^391^33
 ;;^UTILITY(U,$J,358.3,7801,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7801,1,3,0)
 ;;=3^Allergic Purpura
 ;;^UTILITY(U,$J,358.3,7801,1,4,0)
 ;;=4^D69.0
 ;;^UTILITY(U,$J,358.3,7801,2)
 ;;=^5002365
 ;;^UTILITY(U,$J,358.3,7802,0)
 ;;=B00.9^^39^391^161
 ;;^UTILITY(U,$J,358.3,7802,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7802,1,3,0)
 ;;=3^Herpesviral Infection,Unspec
 ;;^UTILITY(U,$J,358.3,7802,1,4,0)
 ;;=4^B00.9
 ;;^UTILITY(U,$J,358.3,7802,2)
 ;;=^5000480
 ;;^UTILITY(U,$J,358.3,7803,0)
 ;;=B02.9^^39^391^331
 ;;^UTILITY(U,$J,358.3,7803,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7803,1,3,0)
 ;;=3^Zoster w/o Complications
 ;;^UTILITY(U,$J,358.3,7803,1,4,0)
 ;;=4^B02.9
 ;;^UTILITY(U,$J,358.3,7803,2)
 ;;=^5000501
 ;;^UTILITY(U,$J,358.3,7804,0)
 ;;=D17.9^^39^391^90
 ;;^UTILITY(U,$J,358.3,7804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7804,1,3,0)
 ;;=3^Benign Lipomatous Neop,Unspec
 ;;^UTILITY(U,$J,358.3,7804,1,4,0)
 ;;=4^D17.9
 ;;^UTILITY(U,$J,358.3,7804,2)
 ;;=^5002020
 ;;^UTILITY(U,$J,358.3,7805,0)
 ;;=E08.621^^39^391^137
 ;;^UTILITY(U,$J,358.3,7805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7805,1,3,0)
 ;;=3^DM d/t Underlying Condition w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,7805,1,4,0)
 ;;=4^E08.621
 ;;^UTILITY(U,$J,358.3,7805,2)
 ;;=^5002534
 ;;^UTILITY(U,$J,358.3,7806,0)
 ;;=E09.621^^39^391^136
 ;;^UTILITY(U,$J,358.3,7806,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7806,1,3,0)
 ;;=3^DM d/t Drug/Chemical w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,7806,1,4,0)
 ;;=4^E09.621
 ;;^UTILITY(U,$J,358.3,7806,2)
 ;;=^5002576
 ;;^UTILITY(U,$J,358.3,7807,0)
 ;;=H05.011^^39^391^112
 ;;^UTILITY(U,$J,358.3,7807,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7807,1,3,0)
 ;;=3^Cellulitis of Right Orbit
 ;;^UTILITY(U,$J,358.3,7807,1,4,0)
 ;;=4^H05.011
 ;;^UTILITY(U,$J,358.3,7807,2)
 ;;=^5004560
 ;;^UTILITY(U,$J,358.3,7808,0)
 ;;=H05.012^^39^391^105
 ;;^UTILITY(U,$J,358.3,7808,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7808,1,3,0)
 ;;=3^Cellulitis of Left Orbit
 ;;^UTILITY(U,$J,358.3,7808,1,4,0)
 ;;=4^H05.012
 ;;^UTILITY(U,$J,358.3,7808,2)
 ;;=^5004561
 ;;^UTILITY(U,$J,358.3,7809,0)
 ;;=H05.013^^39^391^99
 ;;^UTILITY(U,$J,358.3,7809,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7809,1,3,0)
 ;;=3^Cellulitis of Bilateral Orbits
 ;;^UTILITY(U,$J,358.3,7809,1,4,0)
 ;;=4^H05.013
 ;;^UTILITY(U,$J,358.3,7809,2)
 ;;=^5004562
